LEXX Lexaria Bioscience Corp. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
21:52
Jan 21
Jan 21
LEXX GLP-1 MTA could trigger buyout 2-8x
Author claims LEXX's recently released results show a significant decrease in side effects for people on GLP-1 fat drugs using their treatment, positioning them in the race to move GLP-1 to oral intake. LEXX entered a Material Transfer Agreement giving an unnamed 'PharmaCo' (likely Novo) exclusive access to positive results data and a first option to purchase LEXX until April 30, which the author sees as a potential licensing agreement or buyout catalyst within 3 months. Author estimates buyout targets of 2x-8x today's $0.75 price, with investor meetings starting next week as a possible announcement window. Main stated risk is that biotech is fickle and readers should do their own research.
MED
16:13
Jan 04
Jan 04
DehydraTECH oral GLP-1 data makes Lexaria a key delivery platform.
Lexaria's DehydraTECH Phase 1b data showed fewer GI side effects than Rybelsus while achieving metabolic parity and less lean-mass loss, moving the technology into a clinically relevant signal. The same study demonstrated oral feasibility with tirzepatide, suggesting DehydraTECH is a platform while Novo Nordisk's SNAC oral franchise has IP/strategic constraints and Lilly needs oral delivery without adherence issues. With Phase 1b risk retired and funding secured into 2026, Lexaria's delivery technology has become a strategic negotiating lever in the oral GLP-1 race.
HIGH
21:49
Jan 01
Jan 01
GLP-1 play with Q1 catalyst and 2026 potential
The author lists Lexaria as a GLP-1 play with a Q1 catalyst. They add that Lexaria could be a home run for 2026.
MED
About LEXX Investor Commentary
Across the available history and selected sources, Buzzberg tracks LEXX (Lexaria Bioscience Corp.) across 2 sources: 2 bullish vs 0 bearish calls from 2 authors. Historical directional balance: 67% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 3 total trade ideas tracked. Latest voices: u/newtownkid, u/Thescorerocket.